Drug Search Results
More Filters [+]

Pamidronic acid

Alternative Names: pamidronic acid, pamidronate, aredia, pamidronate disodium, disodium pamidronate
Latest Update: 2025-01-17
Latest Update Note: Clinical Trial Update

Product Description

Pamidronic Acid is an amino- bisphosphonate with anti-resorptive and anti-hypercalcemic activities. Pamidronic acid binds to and adsorbs onto hydroxyapatite crystals in the bone matrix, thereby preventing osteoclast resorption. (Sourced from: https://pubchem.ncbi.nlm.nih.gov/compound/Pamidronic-acid)

Mechanisms of Action: Calcium Inhibitor

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Intravenous

FDA Designation: None *

Approval Status: Approved

Approved Countries: Algeria | Argentina | Australia | Austria | Belgium | Brazil | Bulgaria | Canada | Chile | China | Colombia | Croatia | Czech | Denmark | Dominican Republic | Egypt | Finland | France | Germany | Greece | Hong Kong | Hungary | Iceland | India | Ireland | Italy | Japan | Jordan | Korea | Latvia | Lebanon | Lithuania | Luxembourg | Malaysia | Malta | Netherlands | New Zealand | Norway | Pakistan | Peru | Philippines | Poland | Portugal | Romania | Russia | Singapore | Slovakia | Slovenia | Spain | Sri Lanka | Sweden | Switzerland | Taiwan | Thailand | Tunisia | Turkey | Ukraine | United Kingdom | United States | Uruguay | Venezuela | Vietnam

Approved Indications: Hyperparathyroidism | Hypercalcemia | Multiple Myeloma | Bone Cancer | Breast Cancer | Parathyroid Cancer | Thyroid Cancer | Oncology Unspecified

Known Adverse Events: Hypertension | Headache | Pain Unspecified | Anemia | Hypercalcemia | Hypocalcemia | Hypophosphatemia | Multiple Myeloma | Bone Cancer | Breast Cancer | Oncology Unspecified | Dyspnea

Company: None
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Pamidronic acid

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

Recent News Events